DiscoverThe Tox LabEpisode 46: The Kappa Hypothesis - Medetomidine, Dysphoria, and Hallucinations
Episode 46: The Kappa Hypothesis - Medetomidine, Dysphoria, and Hallucinations

Episode 46: The Kappa Hypothesis - Medetomidine, Dysphoria, and Hallucinations

Update: 2025-09-22
Share

Description

This week on The Tox Lab, we’re discussing medetomidine and its unexpected association with hallucinations.


We review a recent paper highlighting its emergence in the drug supply and the apparent increase in hallucinatory effects reported with its use. Although medetomidine has been linked to reducing post-operative delirium, we also discuss a case report of dexmedetomidine-induced delirium in a patient with schizophrenia — adding to the complexity of this picture. And yes, we even wonder what dogs might be dreaming about when they come round from their vet visit.


We then explore a possible mechanism for these effects, including the hypothesis that activity at the kappa opioid receptor could play a role.


We'd love to hear your thoughts on this, so please get in touch!


Hope you enjoy!


Links to the papers we discussed:

https://onlinelibrary.wiley.com/doi/10.1111/dar.70024

https://pmc.ncbi.nlm.nih.gov/articles/PMC11312422/


Disclaimer: All opinions are our own.


Find us on instagram: @the_tox_lab

Email us here: thetoxlab@gmail.com

Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Episode 46: The Kappa Hypothesis - Medetomidine, Dysphoria, and Hallucinations

Episode 46: The Kappa Hypothesis - Medetomidine, Dysphoria, and Hallucinations

The Tox Lab